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Abstract
This report summarizes a brief description/history of the Hydrogen Research Meetings as well as key presentations/
oral abstracts delivered in the most recent symposium. Additionally, we introduced 38 diseases and physiological
states for which hydrogen exhibits beneficial effects.
Introduction
Novel medical gases are expected to provide us with
more effective therapeutic interventions and preventive
medicine. In the past decades, there has been extraor-
dinary, rapid growth in our knowledge of gaseous mole-
cules, including nitric oxide, carbon monoxide, and
hydrogen sulfide, which have been known to play
important roles in biological systems. Additionally, since
Dr. Shigeo Ohta’s group’s pioneering paper was pub-
lished in the June 2007 Nature Medicine showing the
potency of hydrogen as a therapeutic gas for oxidative
stress-mediated diseases including cerebral infarction
[1], basic and clinical hydrogen research has resurfaced.
In Japan, the birthplace of hydrogen gas research, Dr.
Ohta (Nippon Medical School), who is currently serving
as an Associate Editor of Medical Gas Research, orga-
nized annual “Medical Molecular Hydrogen Research
Meetings” in 2009 and 2010 to provide investigators
with focused opportunities to share their rapid scientific
progress. Most recently, we organized the Medical
Molecular Hydrogen Symposium on February 18-19,
2011 at the Nagoya University Hall (Figure 1). The latest
meeting is a “kick-off” inaugural meeting for the newly
launched journal Medical Gas Research (MGR), which
aims to promote the exchange and dissemination of the
latest scientific findings.
This report summarizes a brief description/history of
the Hydrogen Research Meetings as well as key presen-
tations/oral abstracts delivered in the most recent
symposium.
First Medical Molecular Hydrogen Research
Meeting, 2009
The first scientific meeting organized by Dr. Ohta was held
on February 7, 2009 in Tokyo. 42 scientists and clinicians
from 30 individual institutes were invited. The aim of the
meeting was to unite innovative investigators to discuss
and propagate medical hydrogen research. Dr. Ohta deliv-
ered the keynote presentation, in which he gave a brief his-
tory of hydrogen medicine and emphasized the huge
impact of his report published in Nature Medicine. He
pointed out the great interest in the field, expressed in
more than 30 personal communications with investigators,
and the resulting need to widen the scope of basic/clinical
research to the whole world. He mentioned the successful
application of hydrogen gas in a rat neonatal hypoxic brain
injury model in collaboration with Dr. Xuejun Sun (Second
Military Medical School, Shanghai, China) [2], who is cur-
rently serving as an Associate Editor. Dr. Atsunori Nakao
(Department of Surgery, University of Pittsburgh), who is
also an Associate Editor, presented the promising prelimin-
ary results of a collaborative study with Dr. Ohta’s group in
which hydrogen water was applied in a rat kidney trans-
plant model. Dr. Nakao’s report clearly showed survival
benefits for transplant recipients. He received a research
award at this meeting and his report was later published in
Kidney International [3,4]. Dr. Takahisa Kawai (Forsythe
Research Institute, Boston, MA, USA), who is an editorial
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board member, focused on hydrogen generated by intest-
inal bacteria. His initial studies elegantly demonstrated the
critical physiological roles of gut microflora-derived hydro-
gen [5]. There was a general consensus that both clinicians
and researchers in the field of molecular hydrogen research
should gather and exchange accumulating knowledge in
future annual meetings.
Second Medical Molecular Hydrogen Research
Meeting, 2010
The second meeting was also organized by Dr. Ohta on
February 3, 2010 in Tokyo. 47 basic scientists and clinical
physicians, as well as 23 corporate participants were
invited and shared the latest developments in medical
issues related to hydrogen. This meeting hosted a keynote
lecture, an invited lecture, two special lectures, and twelve
platform presentations. After Dr. Ohta began his keynote
lecture by remarking on the impressive progress over the
last year, Dr. Sun gave an invited lecture and introduced
the great effects of intraperitoneal administration of saline
dissolved with H2 in several model animals. Dr. Takashi
Asada (Department of Psychiatry, Tsukuba University), an
authority on Alzheimer disease, presented the results of
clinical studies involving patients with mild cognitive
impairment (MCI). He started clinical intervention studies
on MCI patients by orally administering hydrogen water;
the project is still in progress. Dr. Toru Yoshikawa (Kaoh-
siung Medical University, Taiwan) also gave a special lec-
ture on the physical aspects of hydrogen effects. He
presented the physical characteristics of molecular hydro-
gen’s interaction with water in biological systems.
Third Medical Molecular Hydrogen Research
Meeting, 2011
The third meeting was organized by Dr. Kenji Ohno
(Nagoya University Graduate School of Medicine), an
editorial board member, and held in Nagoya on Feb 18-
19, 2011. This symposium mainly focused on molecular
hydrogen and covered a wide-range of therapeutic gases,
including hydrogen sulfide (H2S), nitric oxide (NO), and
carbon monoxide (CO). A total of 98 academic and 53
corporate registrants attended the meeting from Japan
(144), USA (5), Korea (1), and Taiwan (1). The meet-
ing’s timetable, titles, and speakers are summarized in
Table 1. We also introduced 38 diseases and physiologi-
cal states for which hydrogen exhibits beneficial effects
(Table 2).
Hydrogen
Dr. Ohta gave a keynote lecture and introduced a num-
ber of hydrogen’s potent efficacies on a broad spectrum
of diseases in animal and human models, as well as the
emerging molecular bases of hydrogen’s effects. He
emphasized the following points: (i) In the three and a
half years since the first hydrogen paper was published
in Nature Medicine, more than 70 original papers have
been published in leading biological/medical journals.
Based on cumulative knowledge, beneficial biological
effects of hydrogen have been established with no
doubt. (ii) There are several ways to intake or consume
hydrogen, including inhaling hydrogen gas, drinking
water dissolved with hydrogen (hydrogen water), taking
a hydrogen bath, injecting hydrogen saline, dropping
hydrogen saline into the eye, and increasing production
of intestinal hydrogen by bacteria. (iii) Hydrogen shows
not only anti-oxidative stress effects, but also has var-
ious anti-inflammatory and anti-allergic effects. (iv) The
primary molecular target of hydrogen remains unknown.
In their first report published in 2007 [1], Dr. Ohta’s
group indicated that cells cultured in H2-rich medium
were protected against oxidative stress by the hydroxyl
radical-scavenging activity of H2; however, recent evi-
dence clearly shows that the scavenging property is not
the only explanation for the potent beneficial effects of
hydrogen. For example, the amount of orally adminis-
tered H2 may not be enough to scavenge hydroxyl radi-
cals. In addition, it is likely that the dwell time of H2 in
the body is too short to scavenge a large amount of
hydroxyl radicals that are continuously generated. (v)
Several reports demonstrate an effect on the regulation
of gene expressions and protein-phosphorylations; how-
ever, the transcriptional factors and kinases involved in
the functions afforded by H2 have not been identified. It
also remains unknown whether the regulations are
directly performed by H2. (vi) The amount of adminis-
tered H2 is independent of the extent of effects. Intest-
inal bacteria seem to produce more than 1 liter of H2
gas per day, whereas the amount of H2 originating from
drinking hydrogen water is less than 50 ml. Neverthe-
less, additional H2 in drinking hydrogen water is
Figure 1 A snap shot of the Medical Molecular Hydrogen
Symposium in 2011.
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Table 1 Scientific Program of the Medical Molecular Hydrogen Symposium in 2011
Feb. 18, 2011 Title Speaker
13:00 Opening Remarks Kinji Ohno, Nagoya Univ.
13:05 Keynote Lecture “Recent progress towards hydrogen medicine” Shigeo Ohta, Nippon Medical Sch.
13:35 Scientific Session I
1. Effects of hydrogen-rich water on kidney functions in SHR.Cg-Leprcp/NDmcr rat - a
metabolic syndrome model rat
Michio Hashimoto, Shimane Univ.
2. Hydrogen-rich UW solution attenuates renal cold ischemia reperfusion injury Toyofumi Abe, Osaka Univ.
3. Therapeutic effect of maternal hydrogen water administration in a rat model of fetal
brain damage
Yukio Mano, Nagoya Univ.
4. Effects of hydrogen water on human skin and hair Yoshiaki Kurita, Hosei Univ.
14:23 Coffee Break
14:50 Scientific Session II
5. Consumption of hydrogen water prevents memory impairment accompanying
neurodegeneration in transgenic mice
Ikuroh Ohsawa, Metropolitan Instittue of
Gerontology
6. Appearance of hydrogen gas in the human skin after the ingestion of hydrogen-rich
water and inhalation of hydrogen gas
Kazutoshi Nose, National Cerebral and
Cardiovascular Center
7. Effectiveness of long-term intake of hydrogen rich water in a patient with MELAS Mikio Hirayama, Kasugai Municipal
Hospital
8. Effectiveness of hydrogen rich water on myopathy Tohru Ibi, Aichi Medical Univ.
9. Inhaled hydrogen gas therapy for prevention of lung transplant-induced ischemia/
reperfusion injury in rats
Tomohiro Kawamura, Univ. of Pittsburgh
15:50 Invited Lecture I “Deadly gas can save a life! -Preclinical studies using carbon
monoxide/hydrogen-”
Atsunori Nakao, Univ. of Pittsburgh
16:30 Break
16:40 Invited Lecture II “Medical Gas Research” John Zhang, Loma Linda Univ.
17:20 Invited Lecture III “A hypothesis on biological protection from space radiation through
the use of therapeutic gases”
Michael P. Schoenfeld, NASA Marshall
Space Flight Center
18:10 Banquet
Feb. 19, 2011
9:30 Symposium I “CO as a therapeutic modality” Organizer: Atsunori Nakao, Univ. of
Pittsburgh
S1-1. Is exhaled carbon monoxide a marker of oxidative stress? Tohru Takahashi, Okayama Prefecture
Univ.
S1-2. A tracer analysis study demonstrates redistribution of endogenous carbon
monoxide from blood to tissue in human body
Makoto Sawano, Saitama Medical Univ.
S1-3. Translational research of carbon monoxide therapy using miniature swine Hisashi Sahara, Kagoshima Univ.
10:30 Special Lecture “Function of hydrogen sulfide and its therapeutic applications” Hideo Kimura, National Center of
Neurology and Psychiatry
11:10 Break
11:20 Scientific Session III
10. Hydrogen from intestinal bacteria is protective for Con A-induced Hepatitis Mikihito Kajiya, The Forsyth Institute
11. Abnormal breath hydrogen production by ingestion of lactulose in Parkinson’s
disease
Masaaki Hirayama, Nagoya Univ.
12. A new portable breath hydrogen analyzer and its clinical application Akito Shimouchi, National Cerebral and
Cardiovascular Center
13. Application of hydrogen water in the dental field Noriyuki Tanaka, Uchida Dental Clinic
12:08 Lunch
12:45 Symposium II “Biological Effects of NO” Hirosuke Kobayashi, Kitasato Univ.
S2-1. NO-ROS cellular signaling mediated via nitrated cyclic nucleotide Hideshi Ihara, Osaka Prefecture Univ.
S2-2. Relationship between protein S-nitrosylation and neuronal death Takashi Uehara, Wakayama Mediccal Univ.
S2-3. Role of nitrosative stress in chronic obstructive pulmonary disease Ryujiro Sugimoto, Iwakuni Clinical Center
S2-4. Effects of simultaneous inhalation of nitric oxide and hydrogen on mouse
myocardial ischemia-reperfusion injury
Hirosuke Kobayashi, Kitasato Univ.
14:15 Scientific Session 4
14. Effect of hydrogen rich water against a progression of disease and a formation of
liver tumor in NASH model mouse
Daisuke Kawai, Okayama Univ.
15. The dynamic movement of H2 in a liver and its effects Naomi Kamimura, Nippon Medical Univ.
16. Molecular hydrogen effectively protects cereulide-induced liver injury by suppressing
apoptosis
Sayaka Sobue, Chubu Univ.
14:51 Closing Remarks Kinji Ohno, Nagoya Univ.
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unambiguously effective. Many mysteries of hydrogen
therapy remain unsolved. He closed his talk by empha-
sizing that the molecular mechanisms underlying the
amazing effects of a very small amount of H2 remain
elusive.
Sixteen platform speakers presented clinical and basic
aspects of the medical application of molecular hydro-
gen. Among them were three treatments for patients
with neurological and dental diseases. Dr. Mikio Hir-
ayama (Department of Neurology, Kasugai City Hospi-
tal) and his colleagues presented their clinical report of
treatment for a patient with mitochondrial encephalo-
myopathy, lactic acidosis, and stroke-like episode
(MELAS) syndrome. He reported that a 33-year-old
female patient was successfully treated by drinking
hydrogen-containing water for one and half years, which
reduced the frequency of episodic cerebral ischemia. Dr.
Tohru Ibi (Department of Neurology, Aichi Medical
School) conducted an open label trial on mitochondrial
disorders and inflammatory myopathies, and demon-
strated a remarkable reduction of several serum markers
specific for myelopathy. He also conducted a double-
blind crossover trial; however, the trial showed no sig-
nificant effects, which was likely due to a small amount
of hydrogen water and to a short observation period.
Both reports suggest that oral administration of hydro-
gen water is likely to be effective for mitochondrial dis-
eases. Dr. Noriyuki Tanaka (Uchida Dental Clinic)
reported that direct dental application of hydrogen
water on injured regions reduced inflammation and pro-
moted healing in dental operations, including tooth
extraction.
Medical Gas Research ’s editor-in-chief Dr. John
Zhang (Department of Neurosurgery, Loma Linda Uni-
versity, CA) gave a greeting talk, introducing the aims
and scope of the journal. Dr. Zhang pointed out the
importance of stimulating medical gas research and
collaborating with a wide-range of people in various
fields.
Table 2 Thirty-eight diseases and physiological states for
which hydrogen effects are reported
Disease/Physiology Species Source of H2 Reference
Brain
Cerebral infarction rodent gas [1]
Superoxide in brain rodent water [6]
Neonatal brain hypoxia rodent gas [2,7]
rodent saline [8]
pig gas [9]
Restraint-induced dementia rodent water [10]
Alzheimer’s disease rodent saline [11]
Senile dementia rodent water [12]
Parkinson’s disease rodent water [13,14]
Hemorrhagic cerebral infarction rodent gas [15]
Traumatic brain injury rodent gas [16]
Spinal cord
Spinal cord injury rodent saline [17]
Eye
Glaucoma rodent eye drop [18]
Corneal alkali-burn rodent eye drop [19]
Ear
Hearing disturbance rodent medium [20]
rodent gas [21]
rodent water [22]
Lung
Lung cancer Cells medium [23]
Oxygen-induced lung injury rodent saline [24,25]
Lung transplantation rodent gas [26]
Heart
Myocardial infarction rodent gas [27]
rodent saline [28]
Heart transplantation rodent gas [29]
Irradiation-induced heart injury rodent water [30]
Liver
Hepatic ischemia rodent gas [31]
Hepatitis rodent bacteria [5]
Obstructive jaundice rodent saline [32]
Kidney
Cisplatin nephropathy rodent gas, water [33]
rodent water [34]
Hemodialysis human dialysis [35,36]
Kidney transplantation rodent water [4]
Pancreas
Acute pancreatitis rodent saline [37]
Intestine
Intestinal graft rodent gas [3]
rodent saline [38,39]
Ulcerative colitis rodent gas [40]
Blood vessel
Atherosclerosis rodent water [41]
Metabolism
Diabetes mellitus type 2 human water [42]
Metabolic syndrome human water [43]
Obesity/Diabetes rodent water [44]
Table 2 Thirty-eight diseases and physiological states for
which hydrogen effects are reported (Continued)
Cancer
Tongue carcinoma cells medium [45]
Inflammation and allergy
Allergy type I rodent water [46]
Sepsis rodent gas [47]
Zymosan-induced inflammation rodent gas [47]
Others
Multipotent stromal cells cells gas [48]
Radiation injury cells medium [49,50]
Although the observations are not directly relevant to diseases, Turmeric [51]
and acarbose [52] increase hydrogen production by intestinal bacteria in
humans.
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Dr. Michael P. Schoenfeld from NASA gave a special
lecture on the potential application of H2 to protect
astronauts from radiation-mediated injury during long
space travel. Cosmic radiation induces serious oxidative
stress, which is one of the major issues to be resolved
by hydrogen research.
Other Medical Gases (NO, CO, and H2S)
Mammals produce NO, CO, and H2S by their native
enzymes; however, mammals lack an enzyme to produce
H2. All four gases modulate signaling pathways and
have some therapeutic effects. Thus, we invited leading
NO, CO, and H2S researchers to the symposium.
Dr. Hideo Kimura (National Center of Neurology and
Psychiatry), an editorial board member, gave a special
lecture on hydrogen sulfide (H2S). Dr. Kimura discov-
ered biological roles for H2S. He reviewed studies on
H2S from past to present and emphasized the potential
for actual medical applications.
Dr. Nakao organized a mini-symposium on carbon
monoxide (CO). In the mini-symposium, the discre-
pancy between the animal and human models was dis-
cussed. CO binds to human hemoglobin more strongly
than to murine hemoglobin; this seems to be the reason
why CO is more toxic in clinical studies.
Dr. Hirosuke Kobayashi (Department of Respiratory
Medicine, Kitasato University), an editorial board mem-
ber, organized a mini-symposium on nitric oxide (NO).
Dr. Kobayashi explained the contradictory properties of
NO; while it is medically beneficial, it is also toxic and
enhances oxidative stress. NO has been approved as a
therapeutic agent in clinical practice. He presented the
amazing effects of inhaling an NO and H2 mixture. NO
enhances oxidative stress and induces production of
peroxynitrite, and H2 reduces peroxynitrite derived from
NO. Indeed, he presented that the mixture of NO and
H2 improves the number of surviving myocytes in a
rodent model of myocardial infarction. The mixture of
NO and H2 may be a promising modality for clinical
applications.
In addition to NO, CO, and H2S, Dr. Zhang addressed
potential effects of inhaled xeon and helium in animal
models in his invited lecture.
Commercial products
Six companies financially supported the meeting by
demonstrating their new commercial products. Melo-
dian Co Ltd. presented a sports drink containing H2,
and Miz Co Ltd. introduced an interesting device to
prepare a clinically applicable H2-rich infusion solution
by simply soaking an infusion bag in hydrogen water.
With this method, no other treatment is necessary to
prepare hydrogen infusion solution without opening the
infusion bag. Taiyo Co Ltd. presented reasonably priced
devices to measure H2 gas in breath. Takaoka Co Ltd.
demonstrated a tiny home apparatus to produce hydro-
gen water. Doctor’s Choice Co Ltd. demonstrated pow-
ders to prepare a hydrogen bath at home using a new
material that releases H2 gas. These new products will
help expand our knowledge and applicability of hydro-
gen research.
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